Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

BNP Secretary General Mirza Fakhrul Islam Alamgir has warned of a severe crisis in the pharmaceutical industry, alleging that ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

A proposed 25% US tariff on drug imports threatens India's pharmaceutical industry, potentially disrupting the supply of ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...

Nigeria’s local manufacturers are recording 12% reduction in the cost of production as a result of the ongoing implementation ...

President Trump has imposed a 15 percent tariff on most items in a trade agreement with the European Union, with ...